Cargando…

Cross-priming of cyclin B1, MUC-1 and survivin-specific CD8(+ )T cells by dendritic cells loaded with killed allogeneic breast cancer cells

INTRODUCTION: The ability of dendritic cells (DCs) to take up whole tumor cells and process their antigens for presentation to T cells ('cross-priming') is an important mechanism for induction of tumor specific immunity. METHODS: In vitro generated DCs were loaded with killed allogeneic br...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saito, Hiroaki, Dubsky, Peter, Dantin, Carole, Finn, Olivera J, Banchereau, Jacques, Palucka, A Karolina
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797030/ https://www.ncbi.nlm.nih.gov/pubmed/17129372 http://dx.doi.org/10.1186/bcr1621

Ejemplares similares

Cross-Priming of Naive Cd8 T Cells against Melanoma Antigens Using Dendritic Cells Loaded with Killed Allogeneic Melanoma Cells
por: Berard, Frederic, et al.
Publicado: (2000)

Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes
por: Neidhardt-Berard, Eve-Marie, et al.
Publicado: (2004)

A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40
por: Chen, Jingtao, et al.
Publicado: (2015)

Will the Making of Plasmacytoid Dendritic Cells in Vitro Help Unravel Their Mysteries?
por: Banchereau, Jacques, et al.
Publicado: (2000)

Breast cancer instructs dendritic cells to prime interleukin 13–secreting CD4(+) T cells that facilitate tumor development
por: Aspord, Caroline, et al.
Publicado: (2007)

Early in vivo signaling profiles in MUC1-specific CD4(+) T cells responding to two different MUC1-targeting vaccines in two different microenvironments
por: Reichenbach, Dawn K., et al.
Publicado: (2013)

Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation
por: Simonetta, Federico, et al.
Publicado: (2019)

Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cells
por: Li, Yumei, et al.
Publicado: (2018)

Expansion of Melanoma-specific Cytolytic CD8(+) T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34(+) Progenitor-derived Dendritic Cells
por: Paczesny, Sophie, et al.
Publicado: (2004)

The importance of MUC1 and cyclin B1 antibodies in nipple aspiration fluid (NAF): preliminary results
por: Soran, A, et al.
Publicado: (2009)

Interleukin 15 Skews Monocyte Differentiation into Dendritic Cells with Features of Langerhans Cells
por: Mohamadzadeh, Mansour, et al.
Publicado: (2001)

Complex of MUC1, CIN85 and Cbl in Colon Cancer Progression and Metastasis
por: Cascio, Sandra, et al.
Publicado: (2015)

Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination
por: Surenaud, Mathieu, et al.
Publicado: (2019)

MUC1‐C drives myeloid leukaemogenesis and resistance to treatment by a survivin‐mediated mechanism
por: Stroopinsky, Dina, et al.
Publicado: (2018)

In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, Whereas Mature Dendritic Cells Are Located in Peritumoral Areas
por: Bell, Diana, et al.
Publicado: (1999)

Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration
por: Cascio, Sandra, et al.
Publicado: (2013)

Complex Carbohydrates Are Not Removed During Processing of Glycoproteins by Dendritic Cells: Processing of Tumor Antigen MUC1 Glycopeptides for Presentation to Major Histocompatibility Complex Class II–restricted T Cells
por: Vlad, Anda M., et al.
Publicado: (2002)

Radiation for hematologic malignancies: from cell killing to immune cell priming
por: Dabaja, Bouthaina, et al.
Publicado: (2023)

Intra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and Metastasis
por: Cascio, Sandra, et al.
Publicado: (2016)

Prevention of Inflammation-Driven Colon Carcinogenesis in Human MUC1 Transgenic Mice by Vaccination with MUC1 DNA and Dendritic Cells
por: Murwanti, Retno, et al.
Publicado: (2023)

Vaccination with dendritic cells loaded with HIV-1 lipopeptides elicits broad T cell immunity and control of viral load in HIV infected patients
por: Levy, Y, et al.
Publicado: (2012)

Prevention of colitis-associated colon cancer using a vaccine to target abnormal expression of the MUC1 tumor antigen
por: Beatty, Pamela, et al.
Publicado: (2012)

P18-11. DALIA: dendritic cell and lipopeptide-induced immunity against AIDS: a phase I trial
por: Banchereau, J, et al.
Publicado: (2009)

Survivin-responsive conditionally replicating adenovirus kills rhabdomyosarcoma stem cells more efficiently than their progeny
por: Tanoue, Kiyonori, et al.
Publicado: (2014)

Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex
por: Fang, Wanxia, et al.
Publicado: (2020)

Identification of Cyclin B1 as a Shared Human Epithelial Tumor-Associated Antigen Recognized by T Cells
por: Kao, Henry, et al.
Publicado: (2001)

Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals
por: Thiébaut, Rodolphe, et al.
Publicado: (2019)

Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands
por: Choi, Haeyoun, et al.
Publicado: (2022)

Local Effects of Regulatory T Cells in MUC1 Transgenic Mice Potentiate Growth of MUC1 Expressing Tumor Cells In Vivo
por: Sugiura, Daisuke, et al.
Publicado: (2012)

MUC1 regulates cyclin D1 gene expression through p120 catenin and β-catenin
por: Liu, X, et al.
Publicado: (2014)

Correction to: Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex
por: Fang, Wanxia, et al.
Publicado: (2021)

miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer
por: Yu, Xiaojie, et al.
Publicado: (2018)

CD1a(+) survivin(+) dendritic cell infiltration in dermal lesions of systemic sclerosis
por: Mokuda, Sho, et al.
Publicado: (2015)

Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell Transplantation
por: Pradier, Amandine, et al.
Publicado: (2020)

Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia
por: Kumar, Bijender, et al.
Publicado: (2022)

Zinc Modulates the Priming of T Helper 1, T Helper 17, and T Regulatory Cells in Allogeneic and Autologous in vitro Models
por: Alrashidi, Hanan E, et al.
Publicado: (2022)

An anti-MUC1-antibody–interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells
por: Heuser, C, et al.
Publicado: (2003)

Allogeneic hematopoietic stem cell transplantation in non‐Hodgkin lymphoma in Switzerland, 30 years of experience: Sooner is better
por: Rebmann, Ekaterina, et al.
Publicado: (2022)

Dendritic cells enhance the activity of human MUC1-stimulated mononuclear cells against breast cancer
por: Wang, Zhenyao, et al.
Publicado: (2013)

Liaisons between Survivin and Plk1 during Cell Division and Cell Death
por: Colnaghi, Rita, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_37leg89aqh8d1rjri3j1k6f4on